Results: A total of 1014 patients were included: 626 (62%) did not develop AF at any point, 202 had kAF (20%), and 186 (18%) had AFDAS
Heres a look inside the program
P = 0.052), with no effect on adiposity (Fig
Research Areas Mitochondrial Health & Aging MTP-131 has been shown to support mitochondrial function and bioenergetics by reducing reactive oxygen species (ROS) and stabilizing mitochondrial membranes, making it vital for aging and age-related diseases.[1][2] Cardiovascular Disease Research has demonstrated that MTP-131 has potential as a cardioprotective peptide, improving cardiac function and reducing ischemic damage in preclinical models of heart disease.[3][4] Neurological Research MTP-131 is explored for its potential in neuroprotection and mitochondrial rescue in neurodegenerative diseases like Alzheimers and Parkinsons disease.[5][6] Muscle Regeneration & Repair MTP-131 has been shown to help improve muscle recovery, increase muscle strength, and support muscle regeneration in research settings focused on skeletal muscle health.[7][8] Cellular Health & Oxidative Stress MTP-131 targets oxidative stress, which is associated with mitochondrial dysfunction, aging, and disease pathogenesis
doi: 10.1186/s13287-019-1509-1 Summary Keywords erectile dysfunction, phosphodiesterase 5 inhibitor, intracavernosal injection, hormonal replacement therapy, vacuum erection device, penile prosthesis implantation, low-intensity extracorporeal shock wave, stem cell injection therapy Citation Wang C-M, Wu B-R, Xiang P, Xiao J and Hu X-C (2023) Management of male erectile dysfunction: From the past to the future
